Latanoprost (free acid)-d4 – 500 µg

Brand:
Cayman
CAS:
1224443-47-3
Storage:
-20
UN-No:
De Minimis - 1231 / 3

Latanoprost (free acid)-d4 (Lat-FA-d4) contains four deuterium atoms at the 3, 3, 4, and 4 positions. It is intended for use as an internal standard for the quantification of Lat-FA by GC- or LC-mass spectrometry. Latanoprost is an F-series prostaglandin (PG) analog which has been approved for use as an ocular hypotensive drug.{1107} It is the isopropyl ester of a PGF2α analog containing an aromatic group (17-phenyl) in the ω-chain. As an isopropyl ester, latanoprost acts as a prodrug which is converted to Lat-FA by endogenous esterase enzymes. Lat-FA is a potent FP receptor agonist with an EC50 value of 3.6 nM for human FP receptors, which is twice the potency of PGF2α and more than 200 times more potent latanoprost.{8322} The efficacy of PG analog esters for the treatment of glaucoma correlates closely with the FP receptor binding affinity of the free acid.{3802} However, Lat-FA is more irritating and less effective than the prodrug latanoprost when applied directly to the eyes of human glaucoma patients.{5358}  

 

Available on backorder

SKU: 316811 - 500 µg Category:

Description

An internal standard for the quantification of latanoprost (free acid) by GC- or LC-MS.


Formal name: 9α,11α,15R-trihydroxy-17-phenyl-18,19,20-trinor-prost-5Z-en-1-oic-3,3,4,4-d4 acid

Synonyms:  17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4|Lat-FA-d4|PhXA 85-d4

Molecular weight: 394.5

CAS: 1224443-47-3

Purity: ≥99% deuterated forms (d1-d4)

Formulation: A solution in methyl acetate